Cognizant Falls as Investors Weigh Earnings Risk and Broader Tech Weakness
Investivoq PriceTracker
Cognizant Technology Solutions (CTSH) is down 4.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The clearest single catalyst is not obvious, but the move appears tied to a risk-off session for technology shares and caution ahead of Cognizant’s third-quarter earnings release scheduled for October 29, 2026. This could also reflect investors digesting the company’s recent deal activity and balance-sheet changes while reassessing near-term demand for IT and AI-related services.
Details:
Sources:
Cognizant, SEC, Yahoo Finance
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CTSH Insider Trading Activity
$CTSH insiders have traded $CTSH stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:
- JATIN P DALAL (Chief Financial Officer) sold 12,000 shares for an estimated $669,168
- JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $301,055.
- ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 6 sales selling 848 shares for an estimated $45,448.
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$CTSH Hedge Fund Activity
We have seen 467 institutional investors add shares of $CTSH stock to their portfolio, and 529 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 14,952,942 shares (+inf%) to their portfolio in Q2 2026, for an estimated $579,127,443
- SG AMERICAS SECURITIES, LLC added 6,957,414 shares (+4285.9%) to their portfolio in Q2 2026, for an estimated $269,460,644
- PZENA INVESTMENT MANAGEMENT LLC added 6,266,810 shares (+30.9%) to their portfolio in Q2 2026, for an estimated $242,713,551
- WELLINGTON MANAGEMENT GROUP LLP removed 4,639,888 shares (-95.6%) from their portfolio in Q2 2026, for an estimated $179,702,862
- MORGAN STANLEY removed 4,323,996 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $167,468,365
- MILLENNIUM MANAGEMENT LLC added 3,925,570 shares (+851.3%) to their portfolio in Q2 2026, for an estimated $152,037,326
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,743,951 shares (+inf%) to their portfolio in Q2 2026, for an estimated $145,003,222
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$CTSH Analyst Ratings
Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Susquehanna issued a "Positive" rating on 05/01/2026
- Guggenheim issued a "Buy" rating on 04/30/2026
- Wells Fargo issued a "Overweight" rating on 04/30/2026
To track analyst ratings and price targets for $CTSH, check out Investivoq's $CTSH forecast page.
$CTSH Price Targets
Multiple analysts have issued price targets for $CTSH recently. We have seen 10 analysts offer price targets for $CTSH in the last 6 months, with a median target of $69.0.
Here are some recent targets:
- Bryan Bergin from TD Cowen set a target price of $47.0 on 06/26/2026
- James Faucette from Morgan Stanley set a target price of $44.0 on 06/23/2026
- Bryan Keane from Citigroup set a target price of $55.0 on 06/09/2026
- Steven Wahrhaftig from Wedbush set a target price of $70.0 on 06/08/2026
- Arvind Ramnani from Truist Securities set a target price of $66.0 on 06/01/2026
- Dan Dolev from Mizuho set a target price of $68.0 on 05/06/2026
- James Friedman from Susquehanna set a target price of $88.0 on 05/01/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.